Additionally, a specific small molecule inhibitor of RNF5 (inh-2) showed efficacy in both F508del-CFTR CFBE41o- cells and primary bronchial epithelial (HBE) cells derived from CF patients homozygous for the F508del variant [50]. This evidence concerns the gene CFTR and cystic fibrosis.